ABBOTT LABORATORIES Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax
ABBOTT LABORATORIES (ABT) reported Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax of -$8.00 million for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-01.
Discontinued › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax · last filed 2019-05-01
- ABBOTT LABORATORIES other comprehensive income (loss), derivatives qualifying as hedges, tax for the quarter ending 2019-03-31 was -$8.00M.
- ABBOTT LABORATORIES other comprehensive income (loss), derivatives qualifying as hedges, tax for the quarter ending 2018-12-31 was $6.00M, a 0.00% change year-over-year.
- ABBOTT LABORATORIES other comprehensive income (loss), derivatives qualifying as hedges, tax for the quarter ending 2018-09-30 was $16.00M.
- ABBOTT LABORATORIES other comprehensive income (loss), derivatives qualifying as hedges, tax for the quarter ending 2018-06-30 was $48.00M.
- ABBOTT LABORATORIES other comprehensive income (loss), derivatives qualifying as hedges, tax for fiscal 2018 was $50.00M.
- ABBOTT LABORATORIES other comprehensive income (loss), derivatives qualifying as hedges, tax for fiscal 2017 was -$43.00M.
- ABBOTT LABORATORIES other comprehensive income (loss), derivatives qualifying as hedges, tax for fiscal 2016 was -$4.00M.
- ABBOTT LABORATORIES other comprehensive income (loss), derivatives qualifying as hedges, tax for fiscal 2015 was -$9.00M, a 137.50% decline from fiscal 2014.
| Period end | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax 3 month | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax 3 month as first filed | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax 6 month | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax 6 month as first filed | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax 9 month | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax 9 month as first filed | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax 12 month | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2019-03-31 | -$8.00M 10-Q · filed 2019-05-01 | -$2.00M derived: sum of 2 quarters · filed 2019-05-01 | $14.00M derived: sum of 3 quarters · filed 2019-05-01 | $62.00M derived: sum of 4 quarters · filed 2019-05-01 | ||||
| 2018-12-31 | $6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | $22.00M derived: sum of 2 quarters · filed 2019-02-22 | $70.00M derived: sum of 3 quarters · filed 2019-02-22 | $50.00M 10-K · filed 2019-02-22 | ||||
| 2018-09-30 | $16.00M 10-Q · filed 2018-10-31 | $64.00M derived: sum of 2 quarters · filed 2018-10-31 | $44.00M 10-Q · filed 2018-10-31 | $50.00M derived: sum of 4 quarters · filed 2019-05-01 | ||||
| 2018-06-30 | $48.00M 10-Q · filed 2018-08-01 | $28.00M 10-Q · filed 2018-08-01 | $34.00M derived: sum of 3 quarters · filed 2019-05-01 | $24.00M derived: sum of 4 quarters · filed 2019-05-01 | ||||
| 2018-03-31 | -$20.00M 10-Q · filed 2019-05-01 | -$14.00M derived: sum of 2 quarters · filed 2019-05-01 | -$24.00M derived: sum of 3 quarters · filed 2019-05-01 | -$39.00M derived: sum of 4 quarters · filed 2019-05-01 | ||||
| 2017-12-31 | $6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | -$4.00M derived: sum of 2 quarters · filed 2019-02-22 | -$19.00M derived: sum of 3 quarters · filed 2019-02-22 | -$43.00M 10-K · filed 2019-02-22 | ||||
| 2017-09-30 | -$10.00M 10-Q · filed 2018-10-31 | -$25.00M derived: sum of 2 quarters · filed 2018-10-31 | -$49.00M 10-Q · filed 2018-10-31 | -$22.00M derived: sum of 4 quarters · filed 2019-02-22 | ||||
| 2017-06-30 | -$15.00M 10-Q · filed 2018-08-01 | -$39.00M 10-Q · filed 2018-08-01 | -$12.00M derived: sum of 3 quarters · filed 2019-02-22 | -$19.00M derived: sum of 4 quarters · filed 2019-02-22 | ||||
| 2017-03-31 | -$24.00M 10-Q · filed 2018-05-02 | $3.00M derived: sum of 2 quarters · filed 2019-02-22 | -$4.00M derived: sum of 3 quarters · filed 2019-02-22 | -$6.00M derived: sum of 4 quarters · filed 2019-02-22 | ||||
| 2016-12-31 | $27.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | $20.00M derived: sum of 2 quarters · filed 2019-02-22 | $18.00M derived: sum of 3 quarters · filed 2019-02-22 | -$4.00M 10-K · filed 2019-02-22 | ||||
| 2016-09-30 | -$7.00M 10-Q · filed 2017-11-02 | -$9.00M derived: sum of 2 quarters · filed 2017-11-02 | -$31.00M 10-Q · filed 2017-11-02 | -$42.00M derived: sum of 4 quarters · filed 2018-02-16 | ||||
| 2016-06-30 | -$2.00M 10-Q · filed 2017-08-02 | -$24.00M 10-Q · filed 2017-08-02 | -$35.00M derived: sum of 3 quarters · filed 2018-02-16 | -$33.00M derived: sum of 4 quarters · filed 2018-02-16 | ||||
| 2016-03-31 | -$22.00M 10-Q · filed 2017-05-03 | -$33.00M derived: sum of 2 quarters · filed 2018-02-16 | -$31.00M derived: sum of 3 quarters · filed 2018-02-16 | -$37.00M derived: sum of 4 quarters · filed 2018-02-16 | ||||
| 2015-12-31 | -$11.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | -$9.00M derived: sum of 2 quarters · filed 2018-02-16 | -$15.00M derived: sum of 3 quarters · filed 2018-02-16 | -$9.00M 10-K · filed 2018-02-16 | ||||
| 2015-09-30 | $2.00M 10-Q · filed 2016-11-03 | -$4.00M derived: sum of 2 quarters · filed 2016-11-03 | $2.00M 10-Q · filed 2016-11-03 | $15.00M derived: sum of 4 quarters · filed 2017-02-17 | ||||
| 2015-06-30 | -$6.00M 10-Q · filed 2016-08-03 | $0.00 10-Q · filed 2016-08-03 | $13.00M derived: sum of 3 quarters · filed 2017-02-17 | $27.00M derived: sum of 4 quarters · filed 2017-02-17 | ||||
| 2015-03-31 | $7.00M 10-Q · filed 2016-05-04 | $19.00M derived: sum of 2 quarters · filed 2017-02-17 | $33.00M derived: sum of 3 quarters · filed 2017-02-17 | $31.00M derived: sum of 4 quarters · filed 2017-02-17 | ||||
| 2014-12-31 | $12.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | $26.00M derived: sum of 2 quarters · filed 2017-02-17 | $24.00M derived: sum of 3 quarters · filed 2017-02-17 | $24.00M 10-K · filed 2017-02-17 | ||||
| 2014-09-30 | $14.00M 10-Q · filed 2015-11-05 | $12.00M derived: sum of 2 quarters · filed 2015-11-05 | $12.00M 10-Q · filed 2015-11-05 | $8.00M derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2014-06-30 | -$2.00M 10-Q · filed 2015-08-04 | -$2.00M 10-Q · filed 2015-08-04 | -$6.00M derived: sum of 3 quarters · filed 2016-02-19 | -$9.00M derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2014-03-31 | $0.00 10-Q · filed 2014-05-07 | -$4.00M derived: sum of 2 quarters · filed 2016-02-19 | -$7.00M derived: sum of 3 quarters · filed 2016-02-19 | -$8.00M derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2013-12-31 | -$4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | -$7.00M derived: sum of 2 quarters · filed 2016-02-19 | -$8.00M derived: sum of 3 quarters · filed 2016-02-19 | -$13.00M 10-K · filed 2016-02-19 | ||||
| 2013-09-30 | -$3.00M 10-Q · filed 2014-11-06 | -$2.67M 10-Q · filed 2013-11-07 | -$4.00M derived: sum of 2 quarters · filed 2014-11-06 | -$9.00M 10-Q · filed 2014-11-06 | -$8.54M 10-Q · filed 2013-11-07 | -$17.34M derived: sum of 4 quarters · filed 2015-02-27 | ||
| 2013-06-30 | -$1.00M 10-Q · filed 2014-08-05 | -$643.00K 10-Q · filed 2013-08-06 | -$6.00M 10-Q · filed 2014-08-05 | -$5.87M 10-Q · filed 2013-08-06 | -$14.34M derived: sum of 3 quarters · filed 2015-02-27 | -$23.87M derived: sum of 4 quarters · filed 2015-02-27 | ||
| 2013-03-31 | -$5.00M 10-Q · filed 2014-05-07 | -$5.23M 10-Q · filed 2013-05-08 | -$13.34M derived: sum of 2 quarters · filed 2015-02-27 | -$22.87M derived: sum of 3 quarters · filed 2015-02-27 | -$21.76M derived: sum of 4 quarters · filed 2015-02-27 | |||
| 2012-12-31 | -$8.34M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | -$17.87M derived: sum of 2 quarters · filed 2015-02-27 | -$16.76M derived: sum of 3 quarters · filed 2015-02-27 | -$29.00M 10-K · filed 2015-02-27 | -$29.42M 10-K · filed 2013-02-15 | |||
| 2012-09-30 | -$9.54M 10-Q · filed 2013-11-07 | -$8.43M derived: sum of 2 quarters · filed 2013-11-07 | -$20.66M 10-Q · filed 2013-11-07 | |||||
| 2012-06-30 | $1.11M 10-Q · filed 2013-08-06 | -$11.13M 10-Q · filed 2013-08-06 | ||||||
| 2012-03-31 | $3.54M 10-Q · filed 2013-05-08 | |||||||
| 2011-12-31 | $28.00M 10-K · filed 2014-02-21 | $19.86M 10-K · filed 2013-02-15 | ||||||
| 2010-12-31 | $20.57M 10-K · filed 2013-02-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |